Compare FULT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FULT | HAE |
|---|---|---|
| Founded | 1882 | 1971 |
| Country | United States | United States |
| Employees | N/A | 3023 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.9B |
| IPO Year | N/A | 1991 |
| Metric | FULT | HAE |
|---|---|---|
| Price | $19.59 | $83.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $20.75 | ★ $88.38 |
| AVG Volume (30 Days) | ★ 1.8M | 671.6K |
| Earning Date | 01-21-2026 | 02-05-2026 |
| Dividend Yield | ★ 3.80% | N/A |
| EPS Growth | 20.91 | ★ 42.54 |
| EPS | 1.91 | ★ 3.44 |
| Revenue | $1,230,470,000.00 | ★ $1,327,850,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.37 | $6.01 |
| P/E Ratio | ★ $10.45 | $24.09 |
| Revenue Growth | ★ 9.56 | N/A |
| 52 Week Low | $14.33 | $47.32 |
| 52 Week High | $21.40 | $87.32 |
| Indicator | FULT | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 66.64 |
| Support Level | $19.09 | $79.06 |
| Resistance Level | $20.08 | $81.27 |
| Average True Range (ATR) | 0.37 | 1.55 |
| MACD | -0.11 | -0.38 |
| Stochastic Oscillator | 30.06 | 88.74 |
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.